Abstract:
The present invention relates to a vaccine composition comprising domestic predominant epidemic genotype strains of bovine viral diarrhea virus for preventing or treating bovine viral diarrhea. When preparing a vaccine by mixing GB44-1 strain, GB45-1 strain, and 08Q723 strain which are the bovine viral diarrhea virus according to the present invention, the vaccine can be valuably used as an effective vaccine for preventing or treating the bovine viral diarrhea since the vaccine is suitable for domestic genotypes and has an outstanding immune function compared to a conventional vaccine, and solves a problem of a conventional vaccine for the bovine viral diarrhea.
Abstract:
본 발명은 중탄산염을 포함하는 염소 흔들이병 치료용 약학적 조성물에 관한 것이다. 본 발명의 중탄산염을 포함하는 염소 흔들이병 치료용 약학적 조성물은 염소 흔들이병에 걸린 염소의 치료에 탁월한 효과를 가지며, 또한 이를 경구적으로 염소에 투여함으로써 집단사육을 하는 염소에 대해 투약이 용이하므로 산업상 이용가능성이 있다.
Abstract:
본 발명은 구제역 바이러스의 O형, A형 및 Asia 1형에 공통적인 면역반응성을 나타내는 단클론항체를 생산하는 하이브리도마 세포주, 구제역 바이러스 O형 VP1 사이트 A에 대한 특이적인 면역반응성과 바이러스 중화능을 나타내는 단클론항체를 생산하는 하이브리도마 세포주, 구제역 바이러스 A형 VP1 사이트 A에 대한 특이적인 면역반응성과 바이러스 중화능을 나타내는 단클론항체를 생산하는 하이브리도마 세포주, 상기 각 하이브리도마 세포주에 의해 생산되는 단클론항체, 상기 단클론항체를 포함하는 구제역 진단 시약, 상기 구제역 진단 시약을 포함하는 구제역 진단 키트 및 구제역 바이러스 중화항체 검출방법 또는 구제역 진단방법에 관한 것이다. 본 발명에 의하면 구제역 바이러스 혈청형에 대한 각각의 항체를 이용하여 구제역 바이러스 진단용 항원을 포획할 필요가 없고, 유전자 재조합 구제역 바이러스 구조단백질을 진단용 항원으로 사용함으로써 종래 차폐시설을 갖춘 실험실에서만 배양이 가능한 구제역 바이러스를 사용하던 방법에 비해 매우 편리하며, 구제역 바이러스 혈청형에 특이적인 단클론항체를 사용하여 각 축종별 이차항체를 따로 사용하는 번거로움 없이 중화항체 검출이 가능하다. 그리고 본 발명의 진단방법은 종래 기술에 비해 검출 민감도와 특이도가 우수하다. 구제역 바이러스, 하이브리도마, 단클론항체, 중화항체, 진단 시약, 진단 키트, 진단방법, 유전자 재조합 구조단백질
Abstract:
PURPOSE: A diagnostic kit for rapid detection of rabies antibodies is provided to rapidly detect the existence according to rabies vaccination within 20 minutes without expensive equipment and to reduce the generation of rabies. CONSTITUTION: A diagnostic kit for rapid detection of rabies antibodies using immunochromatography has a nitrocellulose membrane(30) containing a test line(40) and a control line(50) on a backing card(70). A conjugate pad is overlapped at one side of the nitrocellulose membrane. A sample pad(10) is overlapped on the conjugate pad. An adsorbent pad(60) absorbing blood serum in which the reaction is completed on a backing card is installed at the other side of the nitrocellulose membrane.
Abstract:
PURPOSE: A hybridoma cell line producing monoclonal antibody to foot-and-mouth disease virus and a method for detecting foot-and-mouth disease virus neutralization antibody are provided to ensure detection convenience without capture of antigen. CONSTITUTION: A hybridoma cell line(KCTC 11337BP) produces monoclonal antibody having common immunoreactivity to virus type O, A and Asia 1. A method for detecting foot-and-mouth disease virus neutralization antibody comprises: a step of fixing monoclonal antibody on a solid support; a step of washing to remove antibodies which are not fixed on the solid support; a step of reacting antigen for diagnosing foot-and-mouth disease virus on the solid support; a step of washing the antigens to remove antigens which are not bound to the solid support; and a step of reacting probe-conjugated monoclonal antibody with the antigen.
Abstract:
PURPOSE: A diagnostic method of foot-and-mouth disease using a recombinant FMCV 2C non-structural protein and a monoclonal antibody is provided, thereby more rapidly and accurately diagnosing the foot-and-mouth disease than the prior methods. CONSTITUTION: A gene encoding a recombinant FMCV 2C non-structural protein derived from Korean foot-and-mouth disease virus O/SKR/2000 has the nucleotide sequence of SEQ ID NO: 1. A recombinant vector is prepared by cloning the gene encoding the recombinant FMCV 2C non-structural protein of SEQ ID NO: 1. The recombinant FMCV 2C non-structural protein is expressed by transformation of a cell with the recombinant vector. A hybridoma cell line(KCTC 10137BP) is prepared by introducing the recombinant FMCV 2C non-structural protein into an animal, collecting an immunized cell from the animal and fusing the immunized cell with a cancer cell. A recombinant FMCV 2C non-structural protein specific monoclonal antibody is produced from the hybridoma cell line(KCTC 10137BP). A diagnostic method of foot-and-mouth disease comprises the steps of: (1) diluting the recombinant FMCV 2C non-structural protein specific monoclonal antibody in a coating buffer solution and pouring the diluate on a plate; (2) washing the plate to remove unattached monoclonal antibodies; (3) reacting the recombinant FMCV 2C non-structural protein with the plate; (4) washing the plate to remove unreacted recombinant FMCV 2C non-structural proteins; (5) reacting the testing serum with the plate; (6) washing the plate to remove unreacted testing serum; (7) reacting a conjugate, which binds with an antibody for foot-and-mouth disease virus in the testing serum and has an enzyme, a radioactive material or a fluorescent material, with the testing serum; and (8) measuring intensity of the enzyme reaction, fluorescence reaction or radiation reaction with the conjugate.
Abstract:
PURPOSE: A diagnostic method of foot-and-mouth disease using a recombinant FMCV 2C non-structural protein and a monoclonal antibody is provided, thereby more rapidly and accurately diagnosing the foot-and-mouth disease than the prior methods. CONSTITUTION: A gene encoding a recombinant FMCV 2C non-structural protein derived from Korean foot-and-mouth disease virus O/SKR/2000 has the nucleotide sequence of SEQ ID NO: 1. A recombinant vector is prepared by cloning the gene encoding the recombinant FMCV 2C non-structural protein of SEQ ID NO: 1. The recombinant FMCV 2C non-structural protein is expressed by transformation of a cell with the recombinant vector. A hybridoma cell line(KCTC 10137BP) is prepared by introducing the recombinant FMCV 2C non-structural protein into an animal, collecting an immunized cell from the animal and fusing the immunized cell with a cancer cell. A recombinant FMCV 2C non-structural protein specific monoclonal antibody is produced from the hybridoma cell line(KCTC 10137BP). A diagnostic method of foot-and-mouth disease comprises the steps of: (1) diluting the recombinant FMCV 2C non-structural protein specific monoclonal antibody in a coating buffer solution and pouring the diluate on a plate; (2) washing the plate to remove unattached monoclonal antibodies; (3) reacting the recombinant FMCV 2C non-structural protein with the plate; (4) washing the plate to remove unreacted recombinant FMCV 2C non-structural proteins; (5) reacting the testing serum with the plate; (6) washing the plate to remove unreacted testing serum; (7) reacting a conjugate, which binds with an antibody for foot-and-mouth disease virus in the testing serum and has an enzyme, a radioactive material or a fluorescent material, with the testing serum; and (8) measuring intensity of the enzyme reaction, fluorescence reaction or radiation reaction with the conjugate.